Clinical Trials
1
Active:0
Completed:0
Trial Phases
1 Phases
Phase 1:1
Drug Approvals
0
Drug Approvals
No drug approvals found
This company may not have drug approvals in our database
Clinical Trials
Distribution across different clinical trial phases (1 trials with phase data)• Click on a phase to view related trials
Phase 1
1 (100.0%)Clinical Evaluation of Safety and Tolerability of KDR2-2 Eye Drops in Healthy Volunteers With Pharmacokinetic Assessment
- First Posted Date
- 2020-11-06
- Last Posted Date
- 2020-11-06
- Target Recruit Count
- 62
- Registration Number
- NCT04620109
- Locations
- 🇺🇸
Parexel International, Glendale, California, United States
News
No news found